BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7487648)

  • 1. Case studies in lipid management.
    Tallis GA; Popplewell PY; Phillips PJ
    Aust Fam Physician; 1995 Sep; 24(9):1627-31, 1634-5, 1637. PubMed ID: 7487648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.
    Armstrong DW; Brouillard D; Matangi MF
    Can J Cardiol; 2011; 27(2):167-70. PubMed ID: 21459264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Summary of 'Cholesterol' guideline (first revision) of the Dutch Society of Family Physicians].
    van der Laan JR; Thomas S
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):421-7. PubMed ID: 10719546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New trends in lipid management: eight cases to consider.
    Smith DA
    Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More about cardiovascular disease and lipid management in New Zealand.
    Metcalfe S; Moodie P
    N Z Med J; 2002 Oct; 115(1163):U203. PubMed ID: 12552309
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypercholesterolemia and hypertension--equivalent risk factors?].
    Kaufmann G
    Schweiz Rundsch Med Prax; 1991 Nov; 80(46):1272-7. PubMed ID: 1957090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
    Borghi C; Veronesi M
    Recenti Prog Med; 2003 Oct; 94(10):421-6. PubMed ID: 14619187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of high blood cholesterol.
    Smith MD; McGhan WF
    Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Statins in practice of the vascular surgeon and cardiologist].
    PokrovskiÄ­ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ['Cholesterol' guidelines (first revision) of the Dutch College of Family Physicians; response from internal medicine].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):407-9. PubMed ID: 10719542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention.
    Mukherjee S
    Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508
    [No Abstract]   [Full Text] [Related]  

  • 16. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of cardiovascular diseases in elderly subjects with hypercholesterolemia].
    Bruckert E; Giral P
    Therapie; 2000; 55(6):669-74. PubMed ID: 11234461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.